Skip to main content
. 2022 Jun 16;4(3):dlac064. doi: 10.1093/jacamr/dlac064

Figure 2.

Figure 2.

Mechanisms of carbapenem resistance in COVID-19 patients with CRE superinfections according to type of infection. CLABSI, central-line associated bloodstream infections; KPC, K. pneumoniae carbapenemase; MBL, metallo-β-lactamase.